Pilot Project on the Automatic Design and 3D Printing of Adolescent Idiopathic Scoliosis Braces (Phase 1)
Launched by ST. JUSTINE'S HOSPITAL · Jan 18, 2024
Trial Information
Current as of August 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to create braces for adolescents with Adolescent Idiopathic Scoliosis, a condition that causes an abnormal curve in the spine. The researchers want to see how well a 3D printed brace can fit and support young patients based on specific measurements. The main goal is to find out what design features make the brace both effective and comfortable for the wearer.
To participate in this trial, individuals must be diagnosed with Adolescent Idiopathic Scoliosis and have a certain level of curve in their spine (measured by a Cobb Angle between 20 and 40 degrees). They should also be between the ages of 10 and 15 and be able to understand English or French. Participants will wear the brace for about 30 minutes, during which researchers will gather feedback and measurements to improve the design. It’s important to note that this trial is not yet recruiting participants, but it aims to help create better treatment options for young people with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnostic of Adolescent Idiopathic Scoliosis
- • Risser 0-2
- • Cobb Angle between 20 and 40 degrees
- • Prescription for a brace
- • Able to understand French or English
- Exclusion Criteria:
- • Grade II or higher Spondylolisthesis
- • Neuromuscular disease
- • Past spinal surgery
About St. Justine's Hospital
St. Justine's Hospital is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research. Renowned for its commitment to excellence in patient care and medical education, the hospital serves as a vital center for clinical trials aimed at improving therapeutic options for children. With a multidisciplinary team of experts, St. Justine's Hospital leverages cutting-edge technology and evidence-based practices to facilitate groundbreaking studies that address a wide range of pediatric conditions, ensuring the highest standards of safety and efficacy for its young patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported